Your stomach will thank you later
In a case report, we documented the curious notion that 2 individuals treated with the glucagon-like peptide 1 (GLP-1) receptor agonist (GLP-1RA) liraglutide for obesity and type 2 diabetes, respectively, experienced remarkable improvement of concomitant BAD symptoms (15)
If youre exploring support for your metabolic health journey, theres no need to wait for the next innovation
This accessibility factor often translates to longer treatment durations in practice, which may partly explain why week-by-week results in real-world settings sometimes exceed clinical trial averages
However, newer drugs like tirzepatide (Mounjaro or Zepbound) appear to have similar rates of gastrointestinal side effects compared to semaglutide
Geographic Availability Available in all 50 states (eligibility for compounded meds varies by state) Clinical Oversight and Safety Delivered by board-certified physicians, dietitians, and behavioral therapists